Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kranz

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|March 9, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitisPanayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2017
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitisJohn Liddle, Benjamin Beaufils, Margaret Binnie, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2010
Pyrazolopyridines as potent PDE4B inhibitors: 5-heterocycle SARCharlotte J Mitchell, Stuart P Ballantine, Diane M Coe, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2009
Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administrationMichael D Woodrow, Stuart P Ballantine, Michael D Barker, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|March 9, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitisPanayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2017
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitisJohn Liddle, Benjamin Beaufils, Margaret Binnie, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2010
Pyrazolopyridines as potent PDE4B inhibitors: 5-heterocycle SARCharlotte J Mitchell, Stuart P Ballantine, Diane M Coe, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2009
Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administrationMichael D Woodrow, Stuart P Ballantine, Michael D Barker, et al.
Pageof 2